Fortis Pharma Consulting Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 05390470 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2021

for

FORTIS PHARMA CONSULTING LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

G Smith

SECRETARY:

S Bennett

REGISTERED OFFICE:

22 Great James Street

London

WC1N 3ES

REGISTERED NUMBER:

05390470 (England and Wales)

ACCOUNTANTS:

Russell & Co

Station House

Station Approach

East Horsley

Leatherhead

Surrey

KT24 6QX

FIXED ASSETS

Tangible assets

4

89,616

4,222

Investments

5

10

10

89,626

4,232

CURRENT ASSETS

Debtors

6

919,881

863,884

Cash at bank

1,525,130

445,570

2,445,011

1,309,454

CREDITORS

Amounts falling due within one year

7

575,872

548,642

NET CURRENT ASSETS

1,869,139

760,812

TOTAL ASSETS LESS CURRENT LIABILITIES

1,958,765

765,044

PROVISIONS FOR LIABILITIES

17,027

802

NET ASSETS

1,941,738

764,242

CAPITAL AND RESERVES

Called up share capital

2

2

Retained earnings

1,941,736

764,240

SHAREHOLDERS' FUNDS

1,941,738

764,242

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 16 June 2021 and were signed by:

G Smith - Director

1.	STATUTORY INFORMATION

Fortis Pharma Consulting Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on cost and 20% on cost

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2020 - 9 ) .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2020

14,397

Additions

90,770

Disposals

(5,522

)

At 31 March 2021

99,645

DEPRECIATION

At 1 April 2020

10,175

Charge for year

5,376

Eliminated on disposal

(5,522

)

At 31 March 2021

10,029

NET BOOK VALUE

At 31 March 2021

89,616

At 31 March 2020

4,222

5.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 April 2020

and 31 March 2021

10

NET BOOK VALUE

At 31 March 2021

10

At 31 March 2020

10

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2021

2020

£

£

Trade debtors

571,799

682,337

Amounts owed by group undertakings

76,299

116,259

Other debtors

271,783

65,288

919,881

863,884

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2021

2020

£

£

Trade creditors

8,891

88,913

Taxation and social security

133,860

173,973

Other creditors

433,121

285,756

575,872

548,642